Advertisement

The journal of nutrition, health & aging

, Volume 14, Issue 2, pp 131–135 | Cite as

Consensus statement on dementia education and training in Europe

  • M. Tsolaki
  • V. Papaliagkas
  • G. Anogianakis
  • R. Bernabei
  • M. Emre
  • L. Frolich
  • P.J. Visser
  • J.-P. Michel
  • T. Pirttila
  • M. Olde Rikkert
  • H. Soininen
  • T. Sobow
  • B. Vellas
  • F. Verhey
  • B. Winblad
  • The European Alzheimer Disease Consortium
Article

Abstract

Objectives

The aim of the current statement is to agree on: (1) what is the current situation with education and training on dementia in Europe; (2) what are the minimum educational requirements for professionals (neurologists, psychiatrists, primary care providers, nurses, biologists, neuroradiologists, etc.) regarding Alzheimer’s disease and dementia, and (3) how to start a course of action for the future.

Design

In 2005, a simple questionnaire was sent to members of the European Alzheimer’s Disease Consortium (EADC) concerning the education and training on dementia in their countries. Fourteen universities of the respective countries responded to this simple questionnaire. The answers varied, and the conclusion of this effort was that little was done concerning the training of students and health professionals on dementia. In 2008, another more structured and specified questionnaire was sent to professors in different universities of the same countries.

Results

The answers obtained were different from those of the previous questionnaire and demonstrated that it is very difficult to know about training and education in the field of dementia in every European country.

Conclusion

From the data collected, it seems that although in the recent past little had been done concerning training on dementia, nowadays training has been developed in most European countries, and relevant educational projects exist both for medical students and doctors during their specialty training. Our main purpose is to develop training material or develop specific courses to improve the professional knowledge about dementia so that best medical and non-medical practice is implemented.

Key words

Education Alzheimer’s disease dementia consensus statement Europe 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde Allgemeine Zeitschrift fur Psychiatrie und Psychisch-gerichtliche Medizin. 1907Google Scholar
  2. 2.
    Wimo A, Ljunggren G, Winblad B. Costs of dementia and dementia care: a review. Int J Geriatr Psychiatry 1997; 12: 841–56PubMedCrossRefGoogle Scholar
  3. 3.
    Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, McArdle JJ, Willis RJ, Wallace RB. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology. 2007;29:125–132.PubMedCrossRefGoogle Scholar
  4. 4.
    Ferri C, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M. Alzheimer’s Disease International: Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112–2117.PubMedCrossRefGoogle Scholar
  5. 5.
    Wimo A, Winblad, B, Stoffler A, Wirth Y, Mobius HJ. Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer’s disease. Pharmacoeconomics. 2003;21:327–340.PubMedCrossRefGoogle Scholar
  6. 6.
    Fillit H, Hill J. Economics of dementia and pharmacoeconomics of dementia therapy. Am J Geriatr Pharmacother. 2005;3:39–49.PubMedCrossRefGoogle Scholar
  7. 7.
    Meek PD, McKeithan K, Schumock GT. Economic considerations in Alzheimer’s disease. Pharmacotherapy. 1998;18:68–73.PubMedGoogle Scholar
  8. 8.
    Waldemar G, Dubois B, Emre M, Scheltens P, Tariska P, Rossor M. Diagnosis and management of Alzheimer’s disease and other disorders associated with dementia. The role of neurologists in Europe. European Federation of Neurological Societies. Eur J Neurol. 2000;7:133–144.PubMedCrossRefGoogle Scholar
  9. 9.
    National Institute for Clinical Excellence. Guidance on the use of donepezil, rivastigmine and galantamine for the treatment of Alzheimer’s disease. Available from URL: http://www.nice.org.uk/pdf/ALZHEIMER_full_guidance. pdf [Accessed 16 June 2009].
  10. 10.
    Ruof J, Mittendorf T, Pirk O, von der Schulenburg JM. Diffusion of innovations: treatment of Alzheimer’s disease in Germany. Health Policy. 2002;60:59–66.PubMedCrossRefGoogle Scholar
  11. 11.
    Caltagirone C, Bianchetti A, Di Luca M, Mecocci P, Padovani A, Pirfo E, Scapicchio P, Senin U, Trabucchi M, Musicco M; Italian Association of Psychogeriatrics. Guidelines for the Treatment of Alzheimer’s Disease from the Italian Association of Psychogeriatrics. Drugs & Aging 2005; 22:1–26.CrossRefGoogle Scholar
  12. 12.
    Patterson CJ, Gauthier S, Bergman H, Cohen CA, Feightner JW, Feldman H, Hogan DB. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. CMAJ. 1999;15: S1–15.Google Scholar
  13. 13.
    Hogan DB, Bailey P, Black S, Carswell A, Chertkow H, Clarke B, Cohen C, Fisk JD, Forbes D, Man-Son-Hing M, Lanctôt K, Morgan D, Thorpe L. Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia. CMAJ. 2008;179:787–793.PubMedCrossRefGoogle Scholar
  14. 14.
    Burns A, O’Brien J, BAP Dementia Consensus group, Auriacombe S, Ballard C, Broich K, Bullock R, Feldman H, Ford G, Knapp M, McCaddon A, Iliffe S, Jacova C, Jones R, Lennon S, McKeith I, Orgogozo JM, Purandare N, Richardson M, Ritchie C, Thomas A, Warner J, Wilcock G, Wilkinson D; British Association for Psychopharmacology. Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology. J Psychopharmacol. 2006;20:732–755.PubMedCrossRefGoogle Scholar
  15. 15.
    Hasselbalch SG, Baloyannis S, Denislic M, Dubois B, Oertel W, Rossor M, Tsiskaridze A, Waldemar G. Education and training of European neurologists in dementia. Eur J Neurol. 2007;14:505–509.PubMedCrossRefGoogle Scholar
  16. 16.
    Pfizer Pharmaceuticals. Model Scenario and course on the formation of keypersons. Knowledge of and attitudes to Dementia, 1997.Google Scholar
  17. 17.
    Nivalis, Circle of care for Professionals and for Relatives. The trained professional Janssen Cilag Academy.Google Scholar
  18. 18.
    Tsolaki M, Papaliagkas V et al. Education of Professionals on Alzheimer’s Disease. Eur J of Neurol. 2005;12:294.CrossRefGoogle Scholar

Copyright information

© Serdi and Springer Verlag France 2010

Authors and Affiliations

  • M. Tsolaki
    • 1
  • V. Papaliagkas
    • 2
  • G. Anogianakis
    • 2
  • R. Bernabei
    • 3
  • M. Emre
    • 4
  • L. Frolich
    • 5
  • P.J. Visser
    • 6
  • J.-P. Michel
    • 7
  • T. Pirttila
    • 8
  • M. Olde Rikkert
    • 9
  • H. Soininen
    • 8
  • T. Sobow
    • 10
  • B. Vellas
    • 11
  • F. Verhey
    • 6
  • B. Winblad
    • 12
  • The European Alzheimer Disease Consortium
  1. 1.3rd Department of NeurologyAristotle University of ThessalonikiThessalonikiGreece
  2. 2.Department of Experimental PhysiologyAristotle University of ThessalonikiThessalonikiGreece
  3. 3.Department of GerontologyCatholic University Sacred HeartRomeItaly
  4. 4.Department of Neurology, Istanbul Faculty of MedicineIstanbul UniversityIstanbulTurkey
  5. 5.Abteilung für Gerontopsychiatrie, Zentralinstitut für Seelische Gesundheit, Medizinische Fakultät MannheimUniversität HeidelbergHeidelbergGermany
  6. 6.Department of Psychiatry and NeuropsychologyUniversity of MaastrichtMaastrichtThe Netherlands
  7. 7.University of Geneva Medical SchoolGenevaSwitzerland
  8. 8.Department of NeurologyUniversity of KuopioKuopioFinland
  9. 9.Department of GeriatricsRadboud University Nijmegen Medical CentreNijmegenThe Netherlands
  10. 10.Department of Old Age Psychiatry & Psychotic DisordersMedical University of LodzLodzPoland
  11. 11.Department of Geriatric MedicineUniversity of ToulouseToulouseFrance
  12. 12.Department of GeriatricsStockholmSweden

Personalised recommendations